Cart
sales@molnova.com
LLP2A
CAS No. 874148-50-2
LLP2A( —— )
Catalog No. M16358 CAS No. 874148-50-2
LLP2A is a high-affinity, selective peptidomimetic ligand of α4β1 integrin with IC50 of 2 pM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLLP2A
-
NoteResearch use only, not for human use.
-
Brief DescriptionLLP2A is a high-affinity, selective peptidomimetic ligand of α4β1 integrin with IC50 of 2 pM.
-
DescriptionLLP2A is a high-affinity, selective peptidomimetic ligand of α4β1 integrin with IC50 of 2 pM; shows no binding affinity for α2β1, α6β1, αLβ2 and αMβ2 integrins; can be used to image α4β1-expressing lymphomas with high sensitivity and specificity when conjugated to a near infrared fluorescent dye in a mouse xenograft model.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetIntegrin
-
RecptorIntegrin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number874148-50-2
-
Formula Weight810.953
-
Molecular FormulaC43H54N8O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(S)-6-((1-carbamoylcyclohexyl)amino)-6-oxo-5-((S)-6-((E)-3-(pyridin-3-yl)acrylamido)-2-(2-(4-(3-(o-tolyl)ureido)phenyl)acetamido)hexanamido)hexanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Peng L, et al. Nat Chem Biol. 2006 Jul;2(7):381-9.
2. Beaino W, et al. J Nucl Med. 2014 Nov;55(11):1856-63.
3. Soodgupta D, et al. J Nucl Med. 2016 Apr;57(4):640-5.
molnova catalog
related products
-
MK-0429
MK-0429 is a potent, selective, orally-active nonpeptide αvβ3 integrin inhibitor with IC50 of 0.08 nM in SPAV3 assay.
-
ML165
A high-affinity, selective platelet integrin αIIbβ3 receptor antagonist with IC50 of 96 nM.
-
Lifitegrast sodium
Lifitegrast sodium (SAR-1118-023 sodium) is a small molecule integrin antagonist that inhibits T cell-mediated inflammation by blocking the binding of two important cell surface proteins (lymphocyte function-associated antigen 1 and intercellular adhesion molecule 1), which reduces inflammation of the ocular surface, and may be used in the study of dry eye.
